Skip Navigation

Cardiovascular Research 1997 36(3):337-346; doi:10.1016/S0008-6363(97)00187-9
© 1997 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Smart, S. C
Right arrow Articles by Warltier, D. C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smart, S. C
Right arrow Articles by Warltier, D. C
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1997, European Society of Cardiology

Differential roles of myocardial Ca2+ channels and Na+/Ca2+ exchange in myocardial reperfusion injury in open chest dogs: relative roles during ischemia and reperfusion

Steven C Smart*, Kiran B Sagar and David C Warltier

Division of Cardiology/Hypertension, Department of Medicine and the Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, WI, 53226, USA

* Corresponding author. Medical College of Wisconsin, Department of Medicine, Division of Cardiovascular Medicine, 9200 W. Wisconsin Ave., Milwaukee, WI 53226. Tel. (414) 2576697, Fax (414) 2577291, E-mail ssmart@post.its.mcw.edu

Objective: Compare the roles of Ca2+ channels and Na+/Ca2+ exchange in reperfusion injury (reperfusion ventricular fibrillation and myocardial stunning). Methods: Open chest dogs undergoing 15 minutes of left anterior descending coronary artery occlusion and 3 hours of reperfusion were randomized to controls or intracoronary infusions of the respective antagonists, nifedipine (50 µg/min) or amiloride (5 mg/min), according to five protocols: (A) 40 minutes before occlusion to 30 minutes after reperfusion; (B) 2 minutes before to 5 minutes after reperfusion; (C) 10 minutes before to 10 minutes after reperfusion (two step infusion for nifedipine only 5 µg/min during occlusion and 50 µg/min after reperfusion); and (D) 0 to 30 minutes after reperfusion. The role of Ca2+ channels was further investigated by infusing the agonist, Bay K 8644 (50 µg/min), alone or simultaneously with any protocol B, C, or D infusions altering both reperfusion ventricular fibrillation and myocardial stunning. Results: Effects of the agents on injury did not result from hemodynamic effects or alterations in blood flow. Amiloride had no effect on ventricular fibrillation. Only protocol A infusion of amiloride prevented myocardial stunning. In contrast, protocol A and B infusions of nifedipine prevented both myocardial stunning (p = ns vs. baseline, p<0.01 vs. control) and ventricular fibrillation (0%, p<0.01). Protocol C prevented reperfusion ventricular fibrillation, but not stunning (p = ns vs. control). Protocol D did not alter injury. Bay K 8644 co-treatment reversed the effects of Protocol B infusion of nifedipine. Ventricular fibrillation was common and postischemic function worst in dogs treated with Bay K 8644 alone (protocol B). Conclusion: Myocardial Ca2+ channels contribute to both reperfusion ventricular fibrillation and stunning, whereas Na+/Ca2+ exchange contributes only to stunning. Inhibitors of myocardial Ca2+ channels are protective when infused in high doses just before reperfusion, whereas the efficacy of Na+/Ca2+ exchange inhibitors is dependent on pretreatment.

KEYWORDS Dogs; Amiloride; Nifedipine; Myocardial contraction; Myocardial ischemia; Reperfusion arrhythmias; Reperfusion injury; Stunned myocardium


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
Q.-D. Wang, J. Pernow, P.-O. Sjoquist, and L. Ryden
Pharmacological possibilities for protection against myocardial reperfusion injury
Cardiovasc Res, July 1, 2002; 55(1): 25 - 37.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
R. J. Leone Jr., P. M. Scholz, and H. R. Weiss
Nitroprusside Attenuates Myocardial Stunning Through Reduced Contractile Delay and Time
Experimental Biology and Medicine, March 1, 2000; 223(3): 263 - 269.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.